Alife develops AI-driven software and analytics for fertility clinics to improve IVF decision-making, laboratory efficiency, and patient outcomes. Their platform integrates imaging and clinical data to provide objective embryo scoring, treatment scheduling, and personalized predictions that support clinicians and embryologists.

Key products include Embryo Predict (an FDA-cleared AI tool supporting embryo assessment for transfer decisions), Schedule Predict, Success Predictor, and the Alife Assist platform for EMR integration and clinic workflows. Alife’s solutions are supported by multi-center clinical trials and peer-reviewed publications.

Alife’s mission is to empower fertility teams with data‑driven, scalable tools that increase consistency, lower operating costs, and improve patient experience and outcomes in assisted reproduction.